Align Technology Net Change in Short-term Investments 2010-2024 | ALGN

Align Technology annual/quarterly net change in short-term investments history and growth rate from 2010 to 2024. Net change in short-term investments can be defined as the net cash flows from the sale and purchase of investments defined to be short-term, generally with maturities of less than one year from the purchase date.
  • Align Technology net change in short-term investments for the quarter ending December 31, 2024 was $0.044B, a 25.03% decline year-over-year.
  • Align Technology net change in short-term investments for the twelve months ending December 31, 2024 was $0.118B, a 7.8% decline year-over-year.
  • Align Technology annual net change in short-term investments for 2024 was $0.044B, a 25.03% decline from 2023.
  • Align Technology annual net change in short-term investments for 2023 was $0.058B, a 37.17% decline from 2022.
  • Align Technology annual net change in short-term investments for 2022 was $0.093B, a 147.18% decline from 2021.
Align Technology Annual Net Change in Short-term Investments
(Millions of US $)
2024 $44
2023 $58
2022 $93
2021 $-197
2020 $316
2019 $-208
2018 $204
2017 $-1
2016 $198
2015 $-113
2014 $-177
2013 $-181
2012 $-42
2011 $10
2010 $2
2009 $6
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $13.602B $3.999B
Align Technology manufactures and markets a system of clear aligner therapy, intra-oral scanners and CAD/CAM (computer-aided design and computer-aided manufacturing) digital services used in dentistry, orthodontics, and dental records storage. The clear aligner system corrects malocclusion using nearly invisible and removable appliances that gently move the tooth to a desired final position. Align Technology has 2 operating segments, Clear Aligner, known as the Invisalign system and the CAD/CAM Services which is known as the iTero intra-oral scanners and OrthoCAD services.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $85.362B 20.61
Becton Dickinson (BDX) United States $49.016B 12.14
Cardinal Health (CAH) United States $35.422B 18.55
Straumann Holding AG (SAUHY) Switzerland $21.335B 0.00
Labcorp (LH) United States $20.286B 16.45
Cooper (COO) United States $16.092B 21.34
West Pharmaceutical Services (WST) United States $14.850B 31.13
Henry Schein (HSIC) United States $8.530B 14.63
Merit Medical Systems (MMSI) United States $5.733B 27.72
DENTSPLY SIRONA (XRAY) United States $3.278B 9.79
CONMED (CNMD) United States $1.814B 13.57
STAAR Surgical (STAA) United States $0.863B 0.00
Lifevantage (LFVN) United States $0.158B 16.31
Pro-Dex (PDEX) United States $0.141B 15.48